Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.
about
Peroxisome proliferator-activated receptors (PPARs) and ovarian function--implications for regulating steroidogenesis, differentiation, and tissue remodeling.PPAR-γ agonists and their effects on IGF-I receptor signaling: Implications for cancerRegulation of human aldoketoreductase 1C3 (AKR1C3) gene expression in the adipose tissueAdPLA ablation increases lipolysis and prevents obesity induced by high-fat feeding or leptin deficiencyIdentification and functional characterization of adipose-specific phospholipase A2 (AdPLA)Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapyModulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modificationsProtein lysine acetylation by p300/CBPIdentification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gammaPeriorbital fat atrophy - an unfamiliar side effect of prostaglandin analoguesChanges to upper eyelid orbital fat from use of topical bimatoprost, travoprost, and latanoprostCorepressors selectively control the transcriptional activity of PPARgamma in adipocytesActivation of protein kinase A and exchange protein directly activated by cAMP promotes adipocyte differentiation of human mesenchymal stem cellsAlleviation of high-fat diet-induced fatty liver damage in group IVA phospholipase A2-knockout micePeroxisome proliferator-activated receptor gamma1 (PPAR-gamma1) as a major PPAR in a tissue in which estrogen induces peroxisome proliferation.Peroxisome proliferator activated receptor-gamma in pathogenesis of experimental fatty liver disease.From preadipocyte to adipocyte: differentiation-directed signals of insulin from the cell surface to the nucleus.Antiobesity mechanisms of action of conjugated linoleic acid.Endogenous synthesis of prostacyclin was positively regulated during the maturation phase of cultured adipocytes.Peroxisome proliferator-activated receptors in the cardiovascular system.Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene.The many facets of PPARgamma: novel insights for the skeleton.Unraveling the complex relationship triad between lipids, obesity, and inflammationSelective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase.Inhibitors of type 5 17β-hydroxysteroid dehydrogenase (AKR1C3): overview and structural insights.Human aldo-keto reductases: Function, gene regulation, and single nucleotide polymorphisms.The ω6-fatty acid, arachidonic acid, regulates the conversion of white to brite adipocyte through a prostaglandin/calcium mediated pathway.Revisiting PPARγ as a target for the treatment of metabolic disordersProstacyclin regulates bone growth via the Epac/Rap1 pathway.Ectodomain shedding of preadipocyte factor 1 (Pref-1) by tumor necrosis factor alpha converting enzyme (TACE) and inhibition of adipocyte differentiationCarbon-nanoparticle-triggered acute lung inflammation and its resolution are not altered in PPARγ-defective (P465L) mice.Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.Prostaglandin profiling reveals a role for haematopoietic prostaglandin D synthase in adipose tissue macrophage polarisation in mice and humans.In vitro study of antiadipogenic profile of latanoprost, travoprost, bimatoprost, and tafluprost in human orbital preadiopocytesPeroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expressionAldo-Keto Reductases 1B in Endocrinology and Metabolism.PPAR Action in Human Placental Development and Pregnancy and Its Complications.Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.Dietary fat and fat types as early determinants of childhood obesity: a reappraisal.PPARgamma in Neuroblastoma.
P2860
Q21245560-18B34AD0-988A-49EE-A160-993D48707340Q21328702-15337ED4-322C-4A53-888E-2DF6428AD969Q24315816-79C53D3D-DB18-47FF-826E-4FBAB7C39911Q24629585-1C71DDE8-9818-45ED-95B7-F3F5FB56D06DQ24652802-519873BB-8C91-48EF-8A43-7F716EA7E140Q24675327-1E02DE86-A81D-4989-921D-E4837CCAD31EQ27015807-B7385085-AA79-43DB-B324-7012D22943FFQ27021749-EB6599D6-B44B-4605-AB56-AF834C2B7F7DQ28144779-DAD21221-C3D7-46DB-A51A-162A0B699091Q28301055-B4128BFD-8FF8-43C2-B0E1-B5D05D609F9BQ28305613-3879970E-05FA-44CA-BA92-1AC3628466A7Q28508812-01787C4B-DD49-4DEE-9059-05CF7B3390B2Q28730910-4AEA08D6-23DD-4C30-9C8C-5E11726F6546Q28750061-1EBA7485-C5A0-460D-92DE-22840698E91EQ32019780-5C45FA6D-EBC8-4A75-B770-7C77403A9AE7Q33202380-C383A097-03A4-4CD9-99FB-1FC45CB78AD6Q33545583-5384D7BE-F003-41A4-8481-F386CF2AD514Q33679156-6B9A99F5-ACD4-4CD7-B2DB-05259331AA23Q33849477-C8365FE5-9CBB-430F-AB4B-28E88954DF53Q33850995-E33B3BF8-CB9A-40A1-A013-47E25BA3BDFAQ33964333-99B3B6C7-CE81-41D1-90F5-7E020CDD3F92Q33994438-4304E53E-2775-42F4-A606-FA61085DFE8DQ34042152-575F0DDA-AE0F-4306-8B77-37A1C3E3E083Q34210726-85A54709-1D46-4ECB-9DDB-548B25CB609BQ34618859-8CDC1D7F-F3E6-4F8B-A5AF-8B2103F725BDQ34632786-51DF8EAA-EC70-4EDD-976B-B91195197CCBQ34684310-FA2E8821-05E1-48C7-BE36-F9CCA6E43FE9Q34798213-49F69435-CF9E-4E38-97CD-33F5CB0A363FQ34982327-ACBFDA1D-BC39-48AD-A675-78F264D7F30BQ35070932-EE40E154-D4B0-40F7-A15D-DCB1675BAA55Q35397274-B602D57A-9DD2-4CE2-A0E3-074950FF3598Q35641787-E1432D7B-C6A0-4598-97F1-9696BC68C328Q35801376-3A617CB8-02F5-4CE6-A852-BCAC7CA0583BQ35860207-E086B306-F729-4604-9B63-065508D38DE9Q36078804-7C6B313B-F70D-4E88-ABCD-0FF8696F8A2CQ36135903-257C6061-4493-44F3-B428-BCC3AE5FC97EQ36446678-C709FE47-37BA-4270-89AA-8A71DDF9C623Q36501176-6185B321-FFF2-4288-9498-8A9967CE751CQ36667798-E20CDEF0-67A7-474B-9185-B2CF303EEE6CQ36678476-0253507B-00CB-4840-B969-13128E05A5BE
P2860
Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@en
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@nl
type
label
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@en
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@nl
prefLabel
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@en
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@nl
P2093
P2860
P356
P1476
Prostaglandins promote and blo ...... ator-activated receptor gamma.
@en
P2093
P2860
P304
P356
10.1074/JBC.273.4.1855
P407
P577
1998-01-01T00:00:00Z